MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
633.83%
Quick Ratio
633.83%
Cash Ratio
93.98%
Debt to Asset Ratio
24.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Cash and cash equivalents
67,685
71,195
246,960
78,438
Marketable securities
375,844
469,537
345,981
350,391
Prepaid expenses and other current assets
12,952
13,662
13,878
11,774
Total current assets
456,481
554,394
606,819
440,603
Operating lease right-of-use assets
50,107
51,657
50,517
53,028
Property and equipment, net
20,007
21,697
22,490
20,498
Restricted cash
968
968
968
968
Other assets
7,977
7,414
7,341
7,375
Total assets
535,540
636,130
688,135
522,472
Accounts payable
12,208
10,293
11,215
8,609
Accrued expenses and other current liabilities
43,267
59,950
54,852
43,957
Operating lease liabilities, current
3,221
3,202
2,824
3,791
Deferred revenue, current
13,324
18,754
17,580
25,993
Total current liabilities
72,020
92,199
86,471
82,350
Operating lease liabilities, net of current portion
54,922
55,453
52,906
52,695
Deferred revenue, net of current portion
5,971
7,585
10,011
15,175
Total liabilities
132,913
155,237
149,388
150,220
Common stock, 0.001 par value 500,000,000 shares authorized as of may31, 2026 and november30, 2025 103,701,511 and 101,807,484 shares issued and outstanding as of may31, 2026 and november30, 2025, respectively
104
103
102
77
Additional paid-in capital
1,582,603
1,571,134
1,541,766
1,297,061
Accumulated other comprehensive income (loss)
-145
56
105
119
Accumulated deficit
-1,179,935
-1,090,400
-1,003,226
-925,005
Total stockholders equity
402,627
480,893
538,747
372,252
Total liabilities and stockholders equity
535,540
636,130
688,135
522,472
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$375,844K Cash and cashequivalents$67,685K Prepaid expenses andother current assets$12,952K Total current assets$456,481K Operating leaseright-of-use assets$50,107K Property and equipment,net$20,007K Other assets$7,977K Restricted cash$968K Total assets$535,540K Total liabilities andstockholders equity$535,540K Total stockholdersequity$402,627K Total liabilities$132,913K Accumulated deficit-$1,179,935K Accumulated othercomprehensive income (loss)-$145K Additional paid-in capital$1,582,603K Total currentliabilities$72,020K Operating leaseliabilities, net of current...$54,922K Deferred revenue, net ofcurrent portion$5,971K Common stock, 0.001 parvalue 500,000,000...$104K Accrued expenses andother current...$43,267K Deferred revenue,current$13,324K Accounts payable$12,208K Operating leaseliabilities, current$3,221K

Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics, Inc. (NRIX)